Document:

HTML Project Proof

    
    
      

      
        Exhibit 4.4

         

        

        WARRANT AGREEMENT

         

        

        between

         

        

        FOCUS IMPACT ACQUISITION CORP.

         

        

        and

         

        

        CONTINENTAL STOCK TRANSFER & TRUST COMPANY

         

        

        THIS WARRANT AGREEMENT (this “Agreement”), dated [●], 2021, is by and between Focus Impact Acquisition Corp., Delaware
          corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”).

         

        

        WHEREAS, on [●], 2021 the Company entered into that certain Private Placement Warrants Purchase Agreement, with Focus Impact Sponsor LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which the Sponsor will purchase an aggregate of 11,200,000 warrants at a price of $1.00 per warrant, simultaneously with the closing of the Offering, bearing the
          legend set forth in Exhibit B hereto (the “Private Placement Warrants”) at a purchase price of $1.00 per Private Placement Warrant. Each Private Placement Warrant entitles the
          holder thereof to purchase one share of Common Stock (as defined below) at a price of $11.50 per share, subject to adjustment as described herein; and

         

        

        WHEREAS, in order to finance the Company’s transaction costs in connection with an intended initial merger, capital stock exchange, asset acquisition, stock purchase, reorganization or
          similar business combination, involving the Company and one or more businesses (a “Business Combination”), the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers
          and directors may, but are not obligated to, loan the Company funds as the Company may require, of which up to $1,500,000 of such loans may be convertible into up to an additional 1,500,000 Private Placement Warrants at a price of $1.00 per
          Private Placement Warrant; and

         

        

        WHEREAS, the Company is engaged in an initial public offering (the “Offering”) of units of the Company’s equity securities,
          each such unit comprised of one share of Common Stock and one-half of one Public Warrant (as defined below) (the “Units”) and, in connection therewith, has determined to issue and
          deliver up to 11,500,000 warrants (including up to an additional 1,500,000 warrants to the extent the Over-allotment Option (defined below) is exercised) to public investors in the Offering (the “Public Warrants” and, together with the Private Placement Warrants, the “Warrants”). Each whole Warrant entitles the holder thereof to purchase one share of Class A
          common stock of the Company, par value $0.0001 per share (“Common Stock”), for $11.50 per share, subject to adjustment as described herein. Only whole Warrants are exercisable. A holder
          of the Public Warrants will not be able to exercise any fraction of a Warrant; and

         

        

        
          
            

        

        
        WHEREAS, the Company has filed with the Securities and Exchange Commission (the “Commission”) a registration statement on
          Form S-1, No. 333-255448 (the “Registration Statement”) and prospectus (the “Prospectus”), for the registration, under the
          Securities Act of 1933, as amended (the “Securities Act”), of the Units, the Public Warrants and the Common Stock included in the Units; and

         

        

        WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer,
          exchange, redemption and exercise of the Warrants; and

         

        

        WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of
          rights, and immunities of the Company, the Warrant Agent and the holders of the Warrants; and

         

        

        WHEREAS, all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the
          Warrant Agent (if a physical certificate is issued), as provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution and delivery of this Agreement.

         

        

        NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

         

        

        1. Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in
            accordance with the terms and conditions set forth in this Agreement.

         

        

        2. Warrants.

         

        

        2.1. Form of Warrant. Each Warrant shall initially be issued in registered form only.

         

        

        2.2. Effect of Countersignature. If a physical certificate is issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement, a certificated Warrant shall be invalid and of no effect and may not
            be exercised by the holder thereof.

         

        

        2.3. Registration.

         

        

        2.3.1. Warrant Register. The Warrant Agent shall maintain books (the “Warrant Register”), for the registration of original issuance and the registration of transfer of
            the Warrants. Upon the initial issuance of the Warrants in book-entry form, the Warrant Agent shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with
            instructions delivered to the Warrant Agent by the Company. Ownership of beneficial interests in the Public Warrants shall be shown on, and the transfer of such ownership shall be effected through, records maintained by institutions that have
            accounts with The Depository Trust Company (the “Depositary”) (such institution, with respect to a Warrant in its account, a “Participant”).

         

        

        
          2

          
            

        

        If the Depositary subsequently ceases to make its book-entry settlement system available for the Public Warrants, the Company may instruct the Warrant Agent regarding making other
          arrangements for book-entry settlement. In the event that the Public Warrants are not eligible for, or it is no longer necessary to have the Public Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to
          the Depositary to deliver to the Warrant Agent for cancellation each book-entry Public Warrant, and the Company shall instruct the Warrant Agent to deliver to the Depositary definitive certificates in physical form evidencing such Warrants (“Definitive Warrant Certificates”) which shall be in the form annexed hereto as Exhibit A.

         

        

        Physical certificates, if issued, shall be signed by, or bear the facsimile signature of, the Chairman of the Board, Chief Executive Officer, President, Chief Financial Officer, Chief
          Operating Officer, General Counsel, Secretary or other principal officer of the Company. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the
          Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance.

         

        

        2.3.2. Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person in whose name such Warrant is registered in the Warrant Register (the “Registered Holder”) as the absolute owner of such Warrant and of each Warrant represented thereby, for the purpose of any exercise thereof, and for all other purposes, and neither the
            Company nor the Warrant Agent shall be affected by any notice to the contrary.

         

        

        2.4. Detachability of Warrants. The Common Stock and Public Warrants comprising the Units shall begin separate trading on the 52nd day following the date of the Prospectus or, if such 52nd day is not on a day, other
            than a Saturday, Sunday or federal holiday, on which banks in New York City are generally open for normal business (a “Business Day”), then on the immediately succeeding Business Day
            following such date, or earlier (the “Detachment Date”) with the consent of Citigroup Global Markets Inc., but in no event shall the Common Stock and the Public Warrants comprising the
            Units be separately traded until (A) the Company has filed a Current Report on Form 8-K with the Commission containing an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the Offering, including the proceeds
            then received by the Company from the exercise by the underwriters of their right to purchase additional Units in the Offering (the “Over-allotment Option”), if the Over-allotment
            Option is exercised prior to the filing of the Current Report on Form 8-K, and (B) the Company issues a press release announcing when such separate trading shall begin.

         

        

        2.5. Fractional Warrants. The Company shall not issue fractional Warrants other than as part of the Units, each of which is comprised of one share of Common Stock and one-half of one whole Public Warrant. If, upon the detachment of
            Public Warrants from the Units or otherwise, a holder of Warrants would be entitled to receive a fractional Warrant, the Company shall round down to the nearest whole number the number of Warrants to be issued to such holder.

         

        

        
          3

          
            

        

        2.6. Private Placement Warrants. The Private Placement Warrants shall be identical to the Public Warrants, except that so long as they are held by the Sponsor or any of its Permitted Transferees (as defined below) the
            Private Placement Warrants: (i) may be exercised for cash or on a “cashless basis,” pursuant to subsection 3.3.1(c) hereof, (ii) including the shares of Common Stock issuable upon exercise of the Private Placement Warrants, may not be
            transferred, assigned or sold until thirty (30) days after the completion by the Company of an initial Business Combination, (iii) shall not be redeemable by the Company pursuant to Section 6.1 hereof and (iv) shall only be redeemable
            by the Company pursuant to Section 6.2 if the Reference Value (as defined below) is less than $18.00 per share (subject to adjustment in compliance with Section 4 hereof); provided, however, that in the case of
            (ii), the Private Placement Warrants and any shares of Common Stock issued upon exercise of the Private Placement Warrants may be transferred by the holders thereof:

         

        

        (a) to the Company’s officers or directors, any affiliates or
            family members of any of the Company’s officers or directors, any members or partners of the Sponsor or their affiliates, any affiliates of the Sponsor, or any employees of such affiliates;

         

        

        (b) in the case of an individual, by gift to a member of one of
            the individual’s immediate family, an estate planning vehicle or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization;

         

        

        (c) in the case of an individual, by virtue of laws of descent
            and distribution upon death of the individual;

         

        

        (d) in the case of an individual, pursuant to a qualified
            domestic relations order;

         

        

        (e) by pro rata distributions for the Sponsor to its members,
            partners, or shareholders pursuant to the Sponsor’s organizational documents;

         

        

        (f) by private sales or transfers made in connection with the
            consummation of the Company’s Business Combination at prices no greater than the price at which the Private Placement Warrants or Common Stock, as applicable, were originally purchased;

         

        

        (g) by virtue of the laws of Delaware or the Sponsor’s
            organizational documents upon liquidation or dissolution of the Sponsor;

         

        

        (h) to the Company for no value for cancellation in connection
            with the consummation of our initial Business Combination;

         

        

        (i) in the event of the Company’s liquidation prior to the
            completion of its initial Business Combination; or

         

          

        
          (j) in the event of the Company’s completion of a liquidation, merger, share
              exchange or other similar transaction which results in all of the public stockholders having the right to exchange their shares of Common Stock for cash, securities or other property subsequent to the completion of the Company’s initial
              Business Combination;

           

            

        

        
          4

          
            

        

        
          provided, however, that, in the case of clauses (a) through (g), these permitted transferees
              (the “Permitted Transferees”) must enter into a written agreement with the Company agreeing to be bound by the transfer restrictions and the other restrictions contained in this
              Agreement.

        

         

        

        3. Terms and Exercise of Warrants.

         

        

        3.1. Warrant Price. Each whole Warrant shall entitle the Registered Holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company the number of shares of Common Stock stated therein,
            at the price of $11.50 per share, subject to the adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price” as used
            in this Agreement shall mean the price per share (including in cash or by payment of Warrants pursuant to a “cashless exercise,” to the extent permitted hereunder) described in the prior sentence at which Common Stock may be purchased at the
            time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than fifteen Business Days (unless otherwise required by the
            Commission, any national securities exchange on which the Warrants are listed or applicable law); provided that the Company shall provide at least five days’ prior written notice of such reduction to Registered Holders of the Warrants; and
            provided further, that any such reduction shall be identical among all of the Warrants.

         

        

        3.2. Duration of
              Warrants. A Warrant may be exercised only during the period (the “Exercise Period”) (A) commencing on the
            later of: (i) the date that is thirty (30) days after the first date on which the Company completes a Business Combination, and (ii) the date that is twelve (12) months from the date of the closing of the Offering, and (B) terminating at the
            earliest to occur of (x) 5:00 p.m., New York City time on the date that is five (5) years after the date on which the Company completes its initial Business Combination, (y) the liquidation of the Company in accordance with the Company’s
            amended and restated certificate of incorporation, as amended from time to time, if the Company fails to complete a Business Combination, and (z) other than with respect to the Private Placement Warrants then held by the Sponsor or its
            Permitted Transferees with respect to a redemption pursuant to Section 6.1 hereof or, if the Reference Value equals or exceeds $18.00 per share (subject to adjustment in compliance with Section 4 hereof), Section 6.2
            hereof, 5:00 p.m., New York City time on the Redemption Date (as defined below) as provided in Section 6.3 hereof (the “Expiration Date”); provided, however,
            that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions, as set forth in subsection 3.3.2 below, with respect to an effective registration statement or a valid exemption therefrom being
            available. Except with respect to the right to receive the Redemption Price (as defined below) (other than with respect to a Private Placement Warrant then held by the Sponsor or its Permitted Transferees in connection with a redemption
            pursuant to Section 6.1 hereof or, if the Reference Value equals or exceeds $18.00 per share (subject to adjustment in compliance with Section 4 hereof), Section 6.2 hereof) in the event of a redemption (as set forth in
            Section 6 hereof), each Warrant (other than a Private Placement Warrant then held by the Sponsor or its Permitted Transferees in the event of a redemption pursuant to Section 6.1 hereof or, if the Reference Value equals or
            exceeds $18.00 per share (subject to adjustment in compliance with Section 4 hereof), Section 6.2 hereof) not exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect
            thereof under this Agreement shall cease at 5:00 p.m. New York City time on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided that the Company shall
            provide at least twenty (20) days prior written notice of any such extension to Registered Holders of the Warrants and, provided further that any such extension shall be identical in duration among all the Warrants.

         

        

        
          5

          
            

        

        3.3. Exercise of Warrants.

         

        

        3.3.1. Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant may be exercised by the Registered Holder thereof by delivering to the Warrant Agent at its corporate trust department (i) the Definitive Warrant
            Certificate evidencing the Warrants to be exercised, or, in the case of a Warrant represented by a book-entry, the Warrants to be exercised (the “Book-Entry Warrants”) on the records
            of the Depositary to an account of the Warrant Agent at the Depositary designated for such purposes in writing by the Warrant Agent to the Depositary from time to time, (ii) an election to purchase (“Election to Purchase”) any Common Stock pursuant to the exercise of a Warrant, properly completed and executed by the Registered Holder on the reverse of the Definitive Warrant Certificate or, in the case of a Book-Entry
            Warrant, properly delivered by the Participant in accordance with the Depositary’s procedures, and (iii) the payment in full of the Warrant Price for each share of Common Stock as to which the Warrant is exercised and any and all applicable
            taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the shares of Common Stock and the issuance of such shares of Common Stock, as follows:

         

        

        (a) in lawful money of the United States, in good certified
            check or good bank draft payable to the order of the Warrant Agent;

         

        

        (b) [Reserved];

         

        

        (c) with respect to any Private Placement Warrant, so long as
            such Private Placement Warrant is held by the Sponsor or a Permitted Transferee, by surrendering the Warrants for that number of shares of Common Stock equal to (i) if in connection with a redemption of Private Placement Warrants pursuant to Section

              6.2 hereof, as provided in Section 6.2 hereof with respect to a Make-Whole Exercise and (ii) in all other scenarios the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants,
            multiplied by the excess of the “Sponsor Exercise Fair Market Value” (as defined in this subsection 3.3.1(c)) less the Warrant Price by (y) the Sponsor Exercise Fair Market
            Value. Solely for purposes of this subsection 3.3.1(c), the “Sponsor Exercise Fair Market Value” shall mean the average last reported sale price of the Common Stock for the ten
            (10) trading days ending on the third (3rd) trading day prior to the date on which notice of exercise of the Private Placement Warrant is sent to the Warrant Agent;

         

        

        
          6

          
            

        

        (d) as provided in Section 6.2 hereof with respect to a
            Make-Whole Exercise; or

         

        

        (e) as provided in Section 7.4 hereof.

         

        

        3.3.2. Issuance of Shares of Common Stock on Exercise. As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment of the Warrant Price (if payment is pursuant to subsection 3.3.1(a)), the
            Company shall issue to the Registered Holder of such Warrant a book-entry position or certificate, as applicable, for the number of shares of Common Stock to which he, she or it is entitled, registered in such name or names as may be directed
            by him, her or it on the share transfer books of the Company, and if such Warrant shall not have been exercised in full, a new book-entry position or countersigned Warrant, as applicable, for the number of shares of Common Stock as to which
            such Warrant shall not have been exercised. Notwithstanding the foregoing, the Company shall not be obligated to deliver any share of Common Stock pursuant to the exercise of a Warrant and shall have no obligation to settle such Warrant
            exercise unless a registration statement under the Securities Act with respect to the shares of Common Stock underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company’s satisfying its
            obligations under Section 7.4 or a valid exemption from registration is available. No Warrant shall be exercisable and the Company shall not be obligated to issue shares of Common Stock upon exercise of a Warrant unless the Common Stock
            issuable upon such Warrant exercise have been registered, qualified or deemed to be exempt from registration or qualification under the securities laws of the state of residence of the Registered Holder of the Warrants. Subject to Section
              4.6 of this Agreement, a Registered Holder of Warrants may exercise its Warrants only for a whole number of shares of Common Stock. The Company may require holders of Public Warrants to settle the Warrant on a “cashless basis” pursuant to
            Section 7.4. If, by reason of any exercise of Warrants on a “cashless basis”, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share of Common Stock, the Company shall
            round down to the nearest whole number, the number of shares of Common Stock to be issued to such holder.

         

        

        3.3.3. Valid Issuance. All shares of Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement shall be validly issued, fully paid and nonassessable.

         

        

        3.3.4. Date of Issuance. Each person in whose name any book-entry position or certificate, as applicable, for shares of Common Stock is issued and who is registered in the share transfer books of the Company shall for all purposes
            be deemed to have become the holder of record of such shares of Common Stock on the date on which the Warrant, or book-entry position representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date
            of delivery of such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date when the share transfer books of the Company or book-entry system of the Warrant Agent are closed, such
            person shall be deemed to have become the holder of such shares of Common Stock at the close of business on the next succeeding date on which the share transfer books or book-entry system are open.

         

        

        
          7

          
            

        

        3.3.5. Maximum Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions contained in this subsection 3.3.5; however, no holder of a Warrant shall be
            subject to this subsection 3.3.5 unless he, she or it makes such election. If the election is made by a holder, the Warrant Agent shall not affect the exercise of the holder’s Warrant, and such holder shall not have the right to
            exercise such Warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess of 9.8% (or such other amount as a
            holder may specify) (the “Maximum Percentage”) of the shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the
            aggregate number of shares of Common Stock beneficially owned by such person and its affiliates shall include the number of shares of Common Stock issuable upon exercise of the Warrant with respect to which the determination of such sentence is
            being made, but shall exclude shares of Common Stock that would be issuable upon (x) exercise of the remaining, unexercised portion of the Warrant beneficially owned by such person and its affiliates and (y) exercise or conversion of the
            unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and its affiliates (including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a
            limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the
            Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the number of outstanding shares of Common Stock, the holder may rely on
            the number of outstanding shares of Common Stock as reflected in (1) the Company’s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the Commission as the case may be,
            (2) a more recent public announcement by the Company or (3) any other notice by the Company or Continental Stock Transfer & Trust Company, as transfer agent (in such capacity, the “Transfer

              Agent”), setting forth the number of shares of Common Stock outstanding. For any reason at any time, upon the written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and in writing
            to such holder the number of shares of Common Stock then outstanding. In any case, the number of issued and outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of equity securities of the
            Company by the holder and its affiliates since the date as of which such number of issued and outstanding shares of Common Stock was reported. By written notice to the Company, the holder of a Warrant may from time to time increase or decrease
            the Maximum Percentage applicable to such holder to any other percentage specified in such notice; provided, however, that any such increase shall not be effective until the sixty-first (61st) day after such notice is delivered
            to the Company.

         

        

        4. Adjustments.

         

        

        4.1. Stock Dividends.

         

        

        
          8

          
            

        

        4.1.1. Split-Ups. If after the date hereof, and subject to the provisions of Section 4.6 below, the number of issued and outstanding shares of Common Stock is increased by a stock dividend payable in shares of Common
            Stock, or by a split-up of shares of Common Stock or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be
            increased in proportion to such increase in the issued and outstanding shares of Common Stock. A rights offering made to all or substantially all holders of the Common Stock entitling holders to purchase shares of Common Stock at a price less
            than the “Historical Fair Market Value” (as defined below) shall be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i) the number of shares of Common Stock actually sold in such rights offering (or
            issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for the Common Stock) multiplied by (ii) one (1) minus the quotient of (x) the price per share of Common Stock paid in such rights
            offering divided by (y) the Historical Fair Market Value. For purposes of this subsection 4.1.1, (i) if the rights offering is for securities convertible into or exercisable for Common Stock, in determining the price payable for Common
            Stock, there shall be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “Historical Fair Market
              Value” means the volume weighted average price of the Common Stock during the ten (10) trading day period ending on the trading day prior to the first date on which the shares of Common Stock trade on the applicable exchange or in the
            applicable market, regular way, without the right to receive such rights. No shares of Common Stock shall be issued at less than their par value.

         

        

        4.1.2. Extraordinary Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, pays to all or substantially all of the holders of Common Stock a dividend or makes a distribution in cash,
            securities or other assets on account of such shares of Common Stock (or other shares into which the Warrants are convertible), other than (a) as described in subsection 4.1.1 above, (b) Ordinary Cash Dividends (as defined below), (c)
            to satisfy the redemption rights of the holders of Common Stock in connection with a proposed initial Business Combination, (d) to satisfy the redemption rights of the holders of Common Stock in connection with a stockholder vote to amend the
            Company’s amended and restated certificate of incorporation (i) that would modify the substance or timing of the Company’s obligation to provide holders of shares of Common Stock the right to have their shares redeemed in connection with the
            Company’s initial Business Combination or to redeem 100% of the Company’s public shares if it does not complete its initial Business Combination within the time period required by the Company’s amended and restated certificate of incorporation,
            as amended from time to time, or (ii) with respect to any other provisions relating to the rights of holders of Common Stock, (e) as a result of the repurchase of
            Common Stock by the Company if a proposed initial Business Combination is presented to the stockholders of the Company for approval or (f) in connection with the redemption
            of public shares upon the failure of the Company to complete its initial Business Combination and any subsequent distribution of its assets upon its liquidation (any such non-excluded event being referred to herein as an “Extraordinary Dividend”), then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and/or the fair
            market value (as determined by the Company’s board of directors (the “Board”), in good faith) of any securities or other assets paid on each share of Common Stock in respect of such
            Extraordinary Dividend. For purposes of this subsection 4.1.2, “Ordinary Cash Dividends” means any cash dividend or cash distribution which, when combined on a per share basis,
            with the per share amounts of all other cash dividends and cash distributions paid on the Common Stock during the 365-day period ending on the date of declaration of such dividend or distribution to the extent it does not exceed $0.50 (which
            amount shall be adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4 and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the
            number of shares of Common Stock issuable on exercise of each Warrant).

         

        

        
          9

          
            

        

        4.2. Aggregation of Shares. If after the date hereof, and subject to the provisions of Section 4.6 hereof, the number of issued and outstanding shares of Common Stock is decreased by a consolidation, combination, reverse
            stock split or reclassification of shares of Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of Common Stock
            issuable on exercise of each Warrant shall be decreased in proportion to such decrease in issued and outstanding shares of Common Stock.

         

        

        4.3. Adjustments in Exercise Price. Whenever the number of shares of Common Stock purchasable upon the exercise of the Warrants is adjusted, as provided in subsection 4.1.1 or Section 4.2 above, the
            Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of shares of Common Stock purchasable upon the exercise of
            the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of shares of Common Stock so purchasable immediately thereafter.

         

        

        4.4. Raising of the Capital in Connection with the Initial
              Business Combination. If (x) the Company issues additional shares of Common Stock or securities convertible into or exercisable or exchangeable for shares of Common
            Stock (“equity-linked securities”) for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less
            than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Board and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any shares of Class B Common
            Stock held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more
            than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the completion of the Company’s initial Business Combination (net of redemptions), and (z) the
            volume-weighted average trading price of Common Stock during the twenty (20) trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the
            $18.00 per share redemption trigger price described in Section 6.1 and Section 6.2 shall be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price and the $10.00 per share
            redemption trigger price described in Section 6.2 shall be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

         

        

        
          10

          
            

        

         4.5. Replacement of
              Securities upon Reorganization, etc. In case of any reclassification or reorganization of the issued and outstanding shares of Common Stock (other than a change under Section

              4.1 or Section 4.2 hereof or that solely affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in
            which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the issued and outstanding shares of Common Stock), or in the case of any sale or conveyance to another corporation or entity
            of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the holders of the Warrants shall thereafter have the right to purchase and receive, upon the basis
            and upon the terms and conditions specified in the Warrants and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of
            shares or stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Warrants would
            have received if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the “Alternative Issuance”); provided, however, that (i) if the
            holders of Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets
            constituting the Alternative Issuance for which each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of Common Stock in such consolidation or merger that
            affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Common Stock (other than a tender, exchange or redemption offer made by the Company in connection
            with redemption rights held by stockholders of the Company as provided for in the Company’s amended and restated certificate of incorporation or as a result of the repurchase of shares of Common Stock by the Company if a proposed initial
            Business Combination is presented to the stockholders of the Company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule
            13d-5(b)(1) under the Exchange Act) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act) and any members of any such group of which any such
            affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act) more than 50% of the issued and outstanding shares of Common Stock, the holder of a Warrant shall be entitled to receive as the
            Alternative Issuance, the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if such Warrant holder had exercised the Warrant prior to the expiration of such tender or
            exchange offer, accepted such offer and all of the Common Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as
            nearly equivalent as possible to the adjustments provided for in this Section 4; provided further that if less than 70% of the consideration receivable by the holders of the Common Stock in the applicable event is payable in the
            form of shares of Common Stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such
            event, and if the Registered Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable event by the Company pursuant to a Current Report on Form 8-K filed with the
            Commission, the Warrant Price shall be reduced by an amount (in dollars) equal to the difference of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no event less than
            zero) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the
            applicable event based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets (assuming zero dividends) (“Bloomberg”). For purposes of calculating
            such amount, (i) Section 6 of this Agreement shall be taken into account, (ii) the price of each share of Common Stock shall be the volume weighted average price of the Common Stock during the ten (10) trading day period ending on the
            trading day prior to the effective date of the applicable event, (iii) the assumed volatility shall be the 90 day volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the
            announcement of the applicable event and (iv) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining term of the Warrant. “Per
              Share Consideration” means (i) if the consideration paid to holders of Common Stock consists exclusively of cash, the amount of such cash per share of Common Stock, and (ii) in all other cases, the volume weighted average price of the
            Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event. If any reclassification or reorganization also results in a change in shares of Common Stock covered
            by subsection 4.1.1, then such adjustment shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3 and this Section 4.4. The provisions of this Section 4.4 shall similarly apply to
            successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event shall the Warrant Price be reduced to less than the par value per share issuable upon exercise of such Warrant.

         

        

        
          11

          
            

        

        4.6. Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares of Common Stock issuable upon exercise of a Warrant, the Company shall give written notice thereof to the Warrant
            Agent, which notice shall state the Warrant Price resulting from such adjustment and the increase or decrease, if any, in the number of shares of Common Stock purchasable at such price upon the exercise of a Warrant, setting forth in reasonable
            detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event specified in Sections 4.1, 4.2, 4.3, 4.4, or 4.5, the Company shall give
            written notice of the occurrence of such event to each holder of a Warrant, at the last address set forth for such holder in the Warrant Register, of the record date or the effective date of the event. Failure to give such notice, or any defect
            therein, shall not affect the legality or validity of such event.

         

        

        4.7. No Fractional Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue fractional shares of Common Stock upon the exercise of Warrants. If, by reason of any adjustment made
            pursuant to this Section 4, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise, round down to the nearest whole number the
            number of shares of Common Stock to be issued to such holder.

         

        

        4.8. Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued after such adjustment may state the same Warrant Price and the same number of
            shares of Common Stock as is stated in the Warrants initially issued pursuant to this Agreement; provided, however, that the Company may at any time in its sole discretion make any change in the form of Warrant that the Company
            may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

         

        

        
          12

          
            

        

        5. Transfer and Exchange of Warrants.

         

        

        5.1. Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register, upon surrender of such Warrant for transfer, properly endorsed
            with signatures properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the
            Warrant Agent. In the case of certificated Warrants, the Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request.

         

        

        5.2. Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more
            new Warrants as requested by the Registered Holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that except as otherwise provided herein or with respect to any Book-Entry
            Warrant, each Book-Entry Warrant may be transferred only in whole and only to the Depositary, to another nominee of the Depositary, to a successor depository, or to a nominee of a successor depository; provided further, however
            that in the event that a Warrant surrendered for transfer bears a restrictive legend (as in the case of the Private Placement Warrants), the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange thereof until the
            Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a restrictive legend.

         

        

        5.3. Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which shall result in the issuance of a warrant certificate or book-entry position for a fraction of a warrant,
            except as part of the Units.

         

        

        5.4. Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

         

        

        5.5. Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of
            this Section 5, and the Company, whenever required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

         

        

        
          13

          
            

        

        5.6. Transfer of Warrants. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together with the Unit in which such Warrant is included, and only for the purpose of effecting, or in conjunction
            with, a transfer or exchange of such Unit. Furthermore, each transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants included in such Unit. Notwithstanding the foregoing, the provisions of this Section

              5.6 shall have no effect on any transfer of Warrants on and after the Detachment Date.

         

        

        6. Redemption.

         

        

        6.1. Redemption of Warrants for Cash. Subject to Section 6.5 hereof, not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any time during the Exercise Period, at the office
            of the Warrant Agent, upon notice to the Registered Holders of the Warrants, as described in Section 6.3 below, at a Redemption Price of $0.01 per Warrant, provided that (a) the Reference Value equals or exceeds $18.00 per share
            (subject to adjustment in compliance with Section 4 hereof) and (b) there is an effective registration statement covering the issuance of the shares of Common Stock issuable upon exercise of the Warrants, and a current prospectus
            relating thereto, available throughout the 30-day Redemption Period (as defined in Section 6.3 below).

         

        

        6.2. Redemption of Warrants for $0.10 per Warrant or Common
              Stock. Subject to Section 6.5 hereof, not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any time during the
            Exercise Period, at the office of the Warrant Agent, upon notice to the Registered Holders of the Warrants, as described in Section 6.3 below, at a Redemption Price of $0.10 per Warrant, provided that (i) the Reference Value
            equals or exceeds $10.00 per share (subject to adjustment in compliance with Section 4 hereof) and (ii) if the Reference Value is less than $18.00 per share (subject to adjustment in compliance with Section 4 hereof), the
            Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants. During the 30-day Redemption Period in connection with a redemption pursuant to this Section 6.2, Registered
            Holders of the Warrants may elect to exercise their Warrants on a “cashless basis” pursuant to subsection 3.3.1 and receive a number of shares of Common Stock determined by reference to the table below, based on the Redemption Date
            (calculated for purposes of the table as the period to expiration of the Warrants) and the “Redemption Fair Market Value” (as such term is defined in this Section 6.2) (a “Make-Whole
              Exercise”). Solely for purposes of this Section 6.2, the “Redemption Fair Market Value” shall mean the volume weighted average price of the Common Stock for the ten
            (10) trading days immediately following the date on which notice of redemption pursuant to this Section 6.2 is sent to the Registered Holders. In connection with any redemption pursuant to this Section 6.2, the Company shall
            provide the Registered Holders with the Redemption Fair Market Value no later than one (1) Business Day after the ten (10) trading day period described above ends.

         

        

        
          14

          
            

        

        
          	
                  Redemption Fair Market Value of Class A Common Stock (period to expiration of warrants)

                	 
	
                  Redemption Date

                	 	
                  < 10.00

                	 	 	 	
                  11.00

                	 	 	 	
                  12.00

                	 	 	 	
                  13.00

                	 	 	 	
                  14.00

                	 	 	 	
                  15.00

                	 	 	 	
                  16.00

                	 	 	 	
                  17.00

                	 	 	
                  > 18.00

                	 
	
                  60 months

                	 	 	
                  0.261

                	 	 	 	
                  0.281

                	 	 	 	
                  0.297

                	 	 	 	
                  0.311

                	 	 	 	
                  0.324

                	 	 	 	
                  0.337

                	 	 	 	
                  0.348

                	 	 	 	
                  0.358

                	 	 	 	
                  0.361

                	 
	
                  57 months

                	 	 	
                  0.257

                	 	 	 	
                  0.277

                	 	 	 	
                  0.294

                	 	 	 	
                  0.310

                	 	 	 	
                  0.324

                	 	 	 	
                  0.337

                	 	 	 	
                  0.348

                	 	 	 	
                  0.358

                	 	 	 	
                  0.361

                	 
	
                  54 months

                	 	 	
                  0.252

                	 	 	 	
                  0.272

                	 	 	 	
                  0.291

                	 	 	 	
                  0.307

                	 	 	 	
                  0.322

                	 	 	 	
                  0.335

                	 	 	 	
                  0.347

                	 	 	 	
                  0.357

                	 	 	 	
                  0.361

                	 
	
                  51 months

                	 	 	
                  0.246

                	 	 	 	
                  0.268

                	 	 	 	
                  0.287

                	 	 	 	
                  0.304

                	 	 	 	
                  0.320

                	 	 	 	
                  0.333

                	 	 	 	
                  0.346

                	 	 	 	
                  0.357

                	 	 	 	
                  0.361

                	 
	
                  48 months

                	 	 	
                  0.241

                	 	 	 	
                  0.263

                	 	 	 	
                  0.283

                	 	 	 	
                  0.301

                	 	 	 	
                  0.317

                	 	 	 	
                  0.332

                	 	 	 	
                  0.344

                	 	 	 	
                  0.356

                	 	 	 	
                  0.361

                	 
	
                  45 months

                	 	 	
                  0.235

                	 	 	 	
                  0.258

                	 	 	 	
                  0.279

                	 	 	 	
                  0.298

                	 	 	 	
                  0.315

                	 	 	 	
                  0.330

                	 	 	 	
                  0.343

                	 	 	 	
                  0.356

                	 	 	 	
                  0.361

                	 
	
                  42 months

                	 	 	
                  0.228

                	 	 	 	
                  0.252

                	 	 	 	
                  0.274

                	 	 	 	
                  0.294

                	 	 	 	
                  0.312

                	 	 	 	
                  0.328

                	 	 	 	
                  0.342

                	 	 	 	
                  0.355

                	 	 	 	
                  0.361

                	 
	
                  39 months

                	 	 	
                  0.221

                	 	 	 	
                  0.246

                	 	 	 	
                  0.269

                	 	 	 	
                  0.290

                	 	 	 	
                  0.309

                	 	 	 	
                  0.325

                	 	 	 	
                  0.340

                	 	 	 	
                  0.354

                	 	 	 	
                  0.361

                	 
	
                  36 months

                	 	 	
                  0.213

                	 	 	 	
                  0.239

                	 	 	 	
                  0.263

                	 	 	 	
                  0.285

                	 	 	 	
                  0.305

                	 	 	 	
                  0.323

                	 	 	 	
                  0.339

                	 	 	 	
                  0.353

                	 	 	 	
                  0.361

                	 
	
                  33 months

                	 	 	
                  0.205

                	 	 	 	
                  0.232

                	 	 	 	
                  0.257

                	 	 	 	
                  0.280

                	 	 	 	
                  0.301

                	 	 	 	
                  0.320

                	 	 	 	
                  0.337

                	 	 	 	
                  0.352

                	 	 	 	
                  0.361

                	 
	
                  30 months

                	 	 	
                  0.196

                	 	 	 	
                  0.224

                	 	 	 	
                  0.250

                	 	 	 	
                  0.274

                	 	 	 	
                  0.297

                	 	 	 	
                  0.316

                	 	 	 	
                  0.335

                	 	 	 	
                  0.351

                	 	 	 	
                  0.361

                	 
	
                  27 months

                	 	 	
                  0.185

                	 	 	 	
                  0.214

                	 	 	 	
                  0.242

                	 	 	 	
                  0.268

                	 	 	 	
                  0.291

                	 	 	 	
                  0.313

                	 	 	 	
                  0.332

                	 	 	 	
                  0.350

                	 	 	 	
                  0.361

                	 
	
                  24 months

                	 	 	
                  0.173

                	 	 	 	
                  0.204

                	 	 	 	
                  0.233

                	 	 	 	
                  0.260

                	 	 	 	
                  0.285

                	 	 	 	
                  0.308

                	 	 	 	
                  0.329

                	 	 	 	
                  0.348

                	 	 	 	
                  0.361

                	 
	
                  21 months

                	 	 	
                  0.161

                	 	 	 	
                  0.193

                	 	 	 	
                  0.223

                	 	 	 	
                  0.252

                	 	 	 	
                  0.279

                	 	 	 	
                  0.304

                	 	 	 	
                  0.326

                	 	 	 	
                  0.347

                	 	 	 	
                  0.361

                	 
	
                  18 months

                	 	 	
                  0.146

                	 	 	 	
                  0.179

                	 	 	 	
                  0.211

                	 	 	 	
                  0.242

                	 	 	 	
                  0.271

                	 	 	 	
                  0.298

                	 	 	 	
                  0.322

                	 	 	 	
                  0.345

                	 	 	 	
                  0.361

                	 
	
                  15 months

                	 	 	
                  0.130

                	 	 	 	
                  0.164

                	 	 	 	
                  0.197

                	 	 	 	
                  0.230

                	 	 	 	
                  0.262

                	 	 	 	
                  0.291

                	 	 	 	
                  0.317

                	 	 	 	
                  0.342

                	 	 	 	
                  0.361

                	 
	
                  12 months

                	 	 	
                  0.111

                	 	 	 	
                  0.146

                	 	 	 	
                  0.181

                	 	 	 	
                  0.216

                	 	 	 	
                  0.250

                	 	 	 	
                  0.282

                	 	 	 	
                  0.312

                	 	 	 	
                  0.339

                	 	 	 	
                  0.361

                	 
	
                  9 months

                	 	 	
                  0.090

                	 	 	 	
                  0.125

                	 	 	 	
                  0.162

                	 	 	 	
                  0.199

                	 	 	 	
                  0.237

                	 	 	 	
                  0.272

                	 	 	 	
                  0.305

                	 	 	 	
                  0.336

                	 	 	 	
                  0.361

                	 
	
                  6 months

                	 	 	
                  0.065

                	 	 	 	
                  0.099

                	 	 	 	
                  0.137

                	 	 	 	
                  0.178

                	 	 	 	
                  0.219

                	 	 	 	
                  0.259

                	 	 	 	
                  0.296

                	 	 	 	
                  0.331

                	 	 	 	
                  0.361

                	 
	
                  3 months

                	 	 	
                  0.034

                	 	 	 	
                  0.065

                	 	 	 	
                  0.104

                	 	 	 	
                  0.150

                	 	 	 	
                  0.197

                	 	 	 	
                  0.243

                	 	 	 	
                  0.286

                	 	 	 	
                  0.326

                	 	 	 	
                  0.361

                	 
	
                  0 months

                	 	 	
                  —

                	 	 	 	
                  —

                	 	 	 	
                  0.042

                	 	 	 	
                  0.115

                	 	 	 	
                  0.179

                	 	 	 	
                  0.233

                	 	 	 	
                  0.281

                	 	 	 	
                  0.323

                	 	 	 	
                  0.361

                	 

        

         

        

        The exact Redemption Fair Market Value and Redemption Date may not be set forth in the table above, in which case, if the Redemption Fair Market Value is between two values in the
          table or the Redemption Date is between two redemption dates in the table, the number of shares of Common Stock to be issued for each Warrant exercised in a Make-Whole Exercise shall be determined by a straight-line interpolation between the
          number of shares set forth for the higher and lower Redemption Fair Market Values and the earlier and later redemption dates, as applicable, based on a 365- or 366-day year, as applicable.

         

        

        The stock prices set forth in the column headings of the table above shall be adjusted as of any date on which the number of shares issuable upon exercise of a Warrant or the Exercise
          Price is adjusted pursuant to Section 4 hereof. If the number of shares of Common Stock issuable upon exercise of a Warrant is adjusted pursuant to Section 4 hereof, the adjusted stock prices in the column headings shall equal the stock
          prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the number of shares deliverable upon exercise of a Warrant immediately prior to such adjustment and the denominator of which is the number of shares
          deliverable upon exercise of a Warrant as so adjusted. The number of shares in the table above shall be adjusted in the same manner and at the same time as the number of shares issuable upon exercise of a Warrant. If the Exercise Price of a
          Warrant is adjusted, (a) in the case of an adjustment pursuant to Section 4.4 hereof, the adjusted stock prices in the column headings shall equal the stock prices immediately prior to such adjustment multiplied by a fraction, the numerator of
          which is the higher of the Market Value and the Newly Issued Price and the denominator of which is $10.00 and (b) in the case of an adjustment pursuant to Section 4.1.2 hereof, the adjusted stock prices in the column headings shall equal the
          stock prices immediately prior to such adjustment less the decrease in the Exercise Price pursuant to such Exercise Price adjustment. In no event shall the number of shares issued in connection with a Make-Whole Exercise exceed 0.361 shares of
          Common Stock per Warrant (subject to adjustment)

         

        

        
          15

          
            

        

        6.3. Date Fixed for, and Notice of, Redemption; Redemption
              Price; Reference Value. In the event that the Company elects to redeem the Warrants pursuant to Sections 6.1 or 6.2, the Company shall fix a date for
            the redemption (the “Redemption Date”). Notice of redemption shall be mailed by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption
            Date (the “30-day Redemption Period”) to the Registered Holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice mailed
            in the manner herein provided shall be conclusively presumed to have been duly given whether or not the Registered Holder received such notice. As used in this Agreement, (a) “Redemption
              Price” shall mean the price per Warrant at which any Warrants are redeemed pursuant to Sections 6.1 or 6.2 and (b) “Reference Value” shall mean the last
            reported sales price of the Common Stock for any twenty (20) trading days within the thirty (30) trading-day period ending on the third trading day prior to the date on which notice of the redemption is given.

         

        

        6.4. Exercise after Notice of Redemption. The Warrants may be exercised, for cash (or, if in connection with a redemption pursuant to Section 6.2 of this Agreement, on a “cashless basis” in accordance with such Section

              6.2) at any time after notice of redemption shall have been given by the Company pursuant to Section 6.3 hereof and prior to the Redemption Date. On and after the Redemption Date, the record holder of the Warrants shall have no
            further rights except to receive, upon surrender of the Warrants, the Redemption Price.

         

        

        6.5. Exclusion of Private Placement Warrants. The Company agrees that (a) the redemption rights provided in Section 6.1 hereof shall not apply to the Private Placement Warrants if at the time of the redemption such Private
            Placement Warrants continue to be held by the Sponsor or its Permitted Transferees and (b) if the Reference Value equals or exceeds $18.00 per share (subject to adjustment in compliance with Section 4 hereof), the redemption rights
            provided in Section 6.2 hereof shall not apply to the Private Placement Warrants if at the time of the redemption such Private Placement Warrants continue to be held by the Sponsor or its Permitted Transferees. However, once such
            Private Placement Warrants are transferred (other than to Permitted Transferees in accordance with Section 2.6 hereof), the Company may redeem the Private Placement Warrants pursuant to Section 6.1 or 6.2 hereof,
            provided that the criteria for redemption are met, including the opportunity of the holder of such Private Placement Warrants to exercise the Private Placement Warrants prior to redemption pursuant to Section 6.4 hereof. Private
            Placement Warrants that are transferred to persons other than Permitted Transferees shall upon such transfer cease to be Private Placement Warrants and shall become Public Warrants under this Agreement, including for purposes of Section 9.8
            hereof.

         

        

        7. Other Provisions Relating to Rights of Holders of Warrants.

         

        

        7.1. No Rights as Stockholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder of the Company, including, without limitation, the right to receive dividends, or other
            distributions, exercise any preemptive rights to vote or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other matter.

         

        

        
          16

          
            

        

        7.2. Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which
            shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or destroyed. Any such new Warrant shall constitute a substitute
            contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

         

        

        7.3. Reservation of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued shares of Common Stock that shall be sufficient to permit the exercise in full of all
            outstanding Warrants issued pursuant to this Agreement.

         

        

        7.4. Registration of Common Stock; Cashless Exercise at
              Company’s Option.

         

        

        7.4.1. Registration of the Common Stock. The Company agrees that as soon as practicable, but in no event later than twenty (20) Business Days after the closing of its initial Business Combination, it shall use its commercially
            reasonable efforts to file with the Commission a registration statement for the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the Warrants. The Company shall use its commercially reasonable
            efforts to cause the same to become effective within sixty (60) Business Days following the closing of its initial Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto,
            until the expiration or redemption of the Warrants in accordance with the provisions of this Agreement. If any such registration statement has not been declared effective by the sixtieth (60th) Business Day following the closing of the
            Business Combination, holders of the Warrants shall have the right, during the period beginning on the sixty-first (61st) Business Day after the closing of
            the Business Combination and ending upon such registration statement being declared effective by the Commission, and during any other period when the Company shall fail to have maintained an effective registration statement covering the
            issuance of the shares of Common Stock issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless basis,” by exchanging the Warrants (in accordance with Section 3(a)(9) of the Securities Act or another exemption) for that
            number of shares of Common Stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of the “Fair Market Value” (as defined
            below) less the Warrant Price by (y) the Fair Market Value and (B) the product of 0.361 multiplied by the number of whole Warrants being exercised. Solely for purposes of this subsection 7.4.1, “Fair Market Value” shall mean the volume-weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the date that notice of exercise is received
            by the Warrant Agent from the holder of such Warrants or its securities broker or intermediary. The date that notice of “cashless exercise” is received by the Warrant Agent shall be conclusively determined by the Warrant Agent. In connection
            with the “cashless exercise” of a Public Warrant, the Company shall, upon request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i) the
            exercise of the Warrants on a “cashless basis” in accordance with this subsection 7.4.1 is not required to be registered under the Securities Act and (ii) the shares of Common Stock issued upon such exercise shall be freely tradable
            under United States federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the Securities Act) of the Company and, accordingly, shall not be required to bear a restrictive legend. Except as provided
            in subsection 7.4.2, for the avoidance of doubt, unless and until all of the Warrants have been exercised or have expired, the Company shall continue to be obligated to comply with its registration obligations under the first three
            sentences of this subsection 7.4.1.

         

        

        
          17

          
            

        

        7.4.2. Cashless Exercise at Company’s Option. If the Common Stock is at the time of any exercise of a Public Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under
            Section 18(b)(1) of the Securities Act, the Company may, at its option, (i) require holders of Public Warrants who exercise Public Warrants to exercise such Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the
            Securities Act as described in subsection 7.4.1 and (ii) in the event the Company so elects, the Company shall (x) not be required to file or maintain in effect a registration statement for the registration, under the Securities Act, of
            the Common Stock issuable upon exercise of the Warrants, notwithstanding anything in this Agreement to the contrary, and (y) use its commercially reasonable efforts to register or qualify for sale the Common Stock issuable upon exercise of the
            Public Warrant under applicable blue sky laws to the extent an exemption is not available.

         

        

        8. Concerning the Warrant Agent and Other Matters.

         

        

        8.1. Payment of Taxes. The Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant Agent in respect of the issuance or delivery of shares of Common Stock upon the
            exercise of the Warrants, but the Company shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares of Common Stock.

         

        

        8.2. Resignation, Consolidation, or Merger of Warrant Agent.

         

        

        8.2.1. Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’
            notice in writing to the Company. If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent. If the Company
            shall fail to make such appointment within a period of thirty (30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant (who shall, with such notice, submit his, her or
            its Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost. Any successor
            Warrant Agent, whether appointed by the Company or by such court, shall be a corporation or other entity organized and existing under the laws of the State of New York, in good standing and having its principal office in the United States of
            America, and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers,
            rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the
            predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request
            of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers,
            rights, immunities, duties, and obligations.

         

        

        
          18

          
            

        

        8.2.2. Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor Warrant Agent and the Transfer Agent for the Common Stock not later
            than the effective date of any such appointment.

         

        

        8.2.3. Merger or Consolidation of Warrant Agent. Any entity into which the Warrant Agent may be merged or with which it may be consolidated or any entity resulting from any merger or consolidation to which the Warrant Agent shall be a
            party shall be the successor Warrant Agent under this Agreement without any further act.

         

        

        8.3. Fees and Expenses of Warrant Agent.

         

        

        8.3.1. Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and shall, pursuant to its obligations under this Agreement, reimburse the Warrant Agent upon
            demand for all expenditures that the Warrant Agent may reasonably incur in the execution of its duties hereunder.

         

        

        8.3.2. Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and delivered all such further and other acts, instruments, and assurances as may
            reasonably be required by the Warrant Agent for the carrying out or performing of the provisions of this Agreement.

         

        

        8.4. Liability of Warrant Agent.

         

        

        8.4.1. Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or desirable that any fact or matter be proved or established by the Company
            prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a statement signed by the Chief
            Executive Officer, the President, the Chief Financial Officer, the Chief Operating Officer, the General Counsel, the Secretary or the Chairman of the Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such
            statement for any action taken or suffered in good faith by it pursuant to the provisions of this Agreement.

         

        

        8.4.2. Indemnity. The Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct, fraud or bad faith. The Company agrees to indemnify the Warrant Agent and save it harmless against any and all
            liabilities, including judgments, out-of-pocket costs and reasonable outside counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement, except as a result of the Warrant Agent’s gross negligence, willful
            misconduct, fraud or bad faith.

         

        

        
          19

          
            

        

        8.4.3. Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution of any Warrant (except its countersignature thereof). The Warrant Agent
            shall not be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible to make any adjustments required under the provisions of Section 4
            hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation or
            warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant to this Agreement or any Warrant or as to whether any shares of Common Stock shall, when issued, be valid and fully paid and non-assessable.

         

        

        8.5. Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms and conditions herein set forth and among other things, shall account promptly to the
            Company with respect to Warrants exercised and concurrently account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of shares of Common Stock through the exercise of the Warrants.

         

        

        8.6. Waiver. The Warrant Agent has no right of set-off or any other right, title, interest or claim of any kind (“Claim”) in, or to any distribution of, the Trust
            Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by and between the Company and Continental Stock Transfer & Trust Company as trustee thereunder) and hereby agrees not to seek recourse,
            reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent hereby waives any and all Claims against the Trust Account and any and all rights to seek access to the Trust Account.

         

        

        9. Miscellaneous Provisions.

         

        

        9.1. Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit of their respective successors and assigns.

         

        

        9.2. Notices. Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or
            overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrant Agent), as
            follows:

         

        

        Focus Impact Acquisition Corp.

        250 Park Avenue, Ste 911

        New York, New York 10177

        Attention: Chief Executive Officer

         

        

        
          20

          
            

        

        with a copy to:

         

        

        Kirkland & Ellis LLP

        601 Lexington Avenue

        New York, New York 10022

        Attention: Peter S. Seligson

         

        

        Any notice, statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when so delivered if
          by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company),
          as follows:

         

        

        Continental Stock Transfer & Trust Company

        One State Street, 30th Floor

        New York, New York 10004

        Attention: Compliance Department

         

        

        9.3. Applicable Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects by the laws of the State of New York. Subject to applicable law,
            the Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the
            Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. The Company hereby waives any objection to such exclusive jurisdiction and
            that such courts represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this paragraph will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the
            federal district courts of the United States of America are the sole and exclusive forum.

         

        

        Any person or entity purchasing or otherwise acquiring any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this Section 9.3.
          If any action, the subject matter of which is within the scope the forum provisions above, is filed in a court other than a court located within the State of New York or the United States District Court for the Southern District of New York (a
          “foreign action”) in the name of any warrant holder, such warrant holder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located within the State of New York or the United States District Court
          for the Southern District of New York in connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of process made upon such warrant holder in any such enforcement
          action by service upon such warrant holder’s counsel in the foreign action as agent for such warrant holder.

         

        

        9.4. Persons Having Rights under this Agreement. Nothing in this Agreement shall be construed to confer upon, or give to, any person, corporation or other entity other than the parties hereto and the Registered Holders of the Warrants
            any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be
            for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the Registered Holders of the Warrants.

         

        

        
          21

          
            

        

        9.5. Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant Agent in the United States of America, for inspection by the Registered Holder of any
            Warrant. The Warrant Agent may require any such holder to submit such holder’s Warrant for inspection by the Warrant Agent.

         

        

        9.6. Counterparts; Electronic Signatures. This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such
            counterparts shall together constitute but one and the same instrument. The words “execution,” “signed,” “signature,” and words of like import in this Agreement or in any other certificate, agreement or document related to this Agreement shall
            include images of manually executed signatures transmitted by facsimile or other electronic format (including, without limitation, “pdf,” “tif” or “jpg”) and other electronic signatures (including, without limitation, DocuSign and AdobeSign).
            The use of electronic signatures and electronic records (including, without limitation, any contract or other record created, generated, sent, communicated, received, or stored by electronic means) shall be of the same legal effect, validity
            and enforceability as a manually executed signature or use of a paper-based record-keeping system to the fullest extent permitted by applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York
            State Electronic Signatures and Records Act and any other applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act or the Uniform Commercial Code.

         

        

        9.7. Effect of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation thereof.

         

        

        9.8. Amendments. This Agreement may be amended by the parties hereto without the consent of any Registered Holder for the purpose of(i) curing any ambiguity or to correct any mistake, including to conform the provisions hereof to the
            description of the terms of the Warrants and this Agreement set forth in the Prospectus, or defective provision contained herein, (ii) amending the definition of “Ordinary Cash Dividend” as contemplated by and in accordance with the second
            sentence of subsection 4.1.2 or (iii) adding or changing any provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the
            rights of the Registered Holders under this Agreement. All other modifications or amendments, including any modification or amendment to increase the Warrant Price or shorten the Exercise Period and any amendment to the terms of only the
            Private Placement Warrants, shall require the vote or written consent of the Registered Holders of 65% of the then-outstanding Public Warrants and, solely with respect to any amendment to the terms of the Private Placement Warrants or any
            provision of this Agreement with respect to the Private Placement Warrants, 65% of the then-outstanding Private Placement Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise
            Period pursuant to Sections 3.1 and 3.2, respectively, without the consent of the Registered Holders.

         

        

        
          22

          
            

        

        9.9. Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision
            hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as
            may be possible and be valid and enforceable.

         

        

        Exhibit A Form of Warrant Certificate

         

        

        Exhibit B Legend — Private Placement Warrants

         

        

        
          23

          
            

          

        

        IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

         

        

        	 	
                FOCUS IMPACT ACQUISITION CORP.

              
	 	 
	 	
                By:

              	 
	 	
                Name:

              
	 	
                Title:

              
	 	 	 
	 	
                CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent

              
	 	 
	 	
                By:

              	 
	 	
                Name:

              
	 	
                Title:

              

         

        

        
          
            [Signature Page to Warrant Agreement]

          

          
            

        

        EXHIBIT A

         

        

        Form of Warrant Certificate

         

        

        
          
            

        

        EXHIBIT B

         

        

        Legend - Private Placement WarrantsExhibit 10.1

  

  

  INVESTMENT MANAGEMENT TRUST AGREEMENT

  

  

  This Investment Management Trust Agreement (this “Agreement”) is made effective as of [●], 2021 by and
    between Focus Impact Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).

  

  

  WHEREAS, the Company’s registration statement on Form S-1, File No. 333-[●] (the “Registration Statement”)
    and prospectus (the “Prospectus”) for the initial public offering of the Company’s units (the “Units”), each of which consists of
    one share of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), and one-half of one warrant, each whole warrant entitling the holder thereof to purchase one
    share of Common Stock (such initial public offering hereinafter referred to as the “Offering”), has been declared effective as of the date hereof by the U.S. Securities and Exchange
    Commission; and

  

  

  WHEREAS, the Company has entered into an Underwriting Agreement (the “Underwriting Agreement”) with Citigroup
    Global Markets Inc. and Goldman Sachs & Co. LLC, as representatives (the “Representatives”) to the several underwriters (the “Underwriters”)

    named therein; and

  

  

  WHEREAS, as described in the Prospectus, $204,000,000 of the gross proceeds of the Offering and sale of the Private Placement Warrants (as defined in the Underwriting
    Agreement) (or $234,600,000 if the Underwriters’ option to purchase additional units is exercised in full) will be delivered to the Trustee to be deposited and held in a segregated trust account located at all times in the United States (the “Trust Account”) for the benefit of the Company and the holders of shares of Common Stock included in the Units issued in the Offering as hereinafter provided (the amount to be delivered to the
    Trustee (and any interest subsequently earned thereon) is referred to herein as the “Property,” the stockholders for whose benefit the Trustee shall hold the Property will be referred to as
    the “Public Stockholders,” and the Public Stockholders and the Company will be referred to together as the “Beneficiaries”); and

  

  

  WHEREAS, pursuant to the Underwriting Agreement, a portion of the Property equal to $7,000,000, or $ 8,650,000 if the Underwriters’ option to purchase additional units
    is exercised in full, is attributable to deferred underwriting discounts and commissions that will be payable by the Company to the Underwriters upon the consummation of the Business Combination (as defined below) (the “Deferred Discount”); and

  

  

  WHEREAS, the Company and the Trustee desire to enter into this Agreement to set forth the terms and conditions pursuant to which the Trustee shall hold the Property.

  

  

  NOW THEREFORE, IT IS AGREED:

  

  

  1.            Agreements and Covenants of Trustee. The Trustee hereby agrees and covenants to:

  

  

  (a)       Hold the Property in trust for the Beneficiaries in accordance with the terms of this Agreement in the Trust Account established by the Trustee in the United
    States at J.P. Morgan Chase Bank, N.A. (or at another U.S. chartered commercial bank with consolidated assets of $100 billion or more) in the United States, maintained by Trustee and at a brokerage institution selected by the Trustee that is reasonably
    satisfactory to the Company;

   

  

  
    
      

  

  
  (b)        Manage, supervise and administer the Trust Account subject to the terms and conditions set forth herein;

  

  

  (c)        In a timely manner, upon the written instruction of the Company, invest and reinvest the Property in United States government securities within the meaning of
    Section 2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of 185 days or less, or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 promulgated under the Investment
    Company Act of 1940, as amended (or any successor rule), which invest only in direct U.S. government treasury obligations, as determined by the Company; the Trustee may not invest in any other securities or assets, it being understood that the Trust
    Account will earn no interest while account funds are uninvested awaiting the Company’s instructions hereunder and the Trustee may earn bank credits or other consideration;

  

  

  (d)      Collect and receive, when due, all principal, interest or other income arising from the Property, which shall become part of the “Property,” as such term is used herein;

  

  

  (e)      Promptly notify the Company and the Representatives of all communications received by the Trustee with respect to any Property requiring action by the Company;

  

  

  (f)       Supply any necessary information or documents as may be requested by the Company (or its authorized agents) in connection with the Company’s preparation of the
    tax returns relating to assets held in the Trust Account;

  

  

  (g)       Participate in any plan or proceeding for protecting or enforcing any right or interest arising from the Property if, as and when instructed by the Company to
    do so;

  

  

  (h)      Render to the Company monthly written statements of the activities of, and amounts in, the Trust Account reflecting all receipts and disbursements of the Trust
    Account;

  

  

  (i)        Commence liquidation of the Trust Account only after and promptly after (x) receipt of, and only in accordance with, the terms of a letter from the Company (“Termination Letter”) in a form substantially similar to that attached hereto as either Exhibit A or Exhibit B, as applicable, signed on behalf of the Company by its Chief Executive
    Officer, Chief Financial Officer or other authorized officer of the Company, and complete the liquidation of the Trust Account and distribute the Property in the Trust Account, including interest earned on the funds held in the Trust Account and not
    previously released to us to pay our income taxes (less up to $100,000 of interest to pay dissolution expenses), only as directed in the Termination Letter and the other documents referred to therein, or (y) upon the date which is the later of (1) 18
    months after the closing of the Offering and (2) such later date as may be approved by the Company’s stockholders in accordance with the Company’s certificate of incorporation (as amended), if a Termination Letter has not been received by the Trustee
    prior to such date, in which case the Trust Account shall be liquidated in accordance with the procedures set forth in the Termination Letter attached as Exhibit B and the Property in the Trust Account, including interest earned on the funds
    held in the Trust Account and not previously released to the Company to pay its income taxes (less up to $100,000 of interest to pay dissolution expenses), shall be distributed to the Public Stockholders of record as of such date. It is acknowledged
    and agreed that there should be no reduction in the principal amount per share initially deposited in the Trust Account;

  

  

  
    2

    
      

  

  (j)        Upon written request from the Company, which may be given from time to time in a form substantially similar to that attached hereto as Exhibit C (a “Tax Payment Withdrawal Instruction”), withdraw from the Trust Account and distribute to the Company the amount of interest earned on the Property requested by the Company to cover any tax
    obligation owed by the Company as a result of assets of the Company or interest or other income earned on the Property, which amount shall be delivered directly to the Company by electronic funds transfer or other method of prompt payment, and the
    Company shall forward such payment to the relevant taxing authority, so long as there is no reduction in the principal amount per share initially deposited in the Trust Account; provided, however, that to the extent there is not
    sufficient cash in the Trust Account to pay such tax obligation, the Trustee shall liquidate such assets held in the Trust Account as shall be designated by the Company in writing to make such distribution (it being acknowledged and agreed that any
    such amount in excess of interest income earned on the Property shall not be payable from the Trust Account). The written request of the Company referenced above shall constitute presumptive evidence that the Company is entitled to said funds, and the
    Trustee shall have no responsibility to look beyond said request;

  

  

  (k)       Upon written request from the Company, which may be given from time to time in a form substantially similar to that attached hereto as Exhibit D (a “Stockholder Redemption Withdrawal Instruction”), the Trustee shall distribute to the remitting brokers on behalf of Public Stockholders redeeming Common Stock the amount required to pay redeemed
    Common Stock from Public Stockholders pursuant to the Company’s certificate of incorporation (as amended); and

   

  

  (l)         Not make any withdrawals or distributions from the Trust Account other than pursuant to Section 1(i), (j) or (k) above.

  

  

  2.            Agreements and Covenants of the Company. The Company hereby agrees and covenants to:

  

  

  (a)      Give all instructions to the Trustee hereunder in writing, signed by the Company’s Chief Executive Officer, Chief Financial Officer or other authorized officer
    of the Company. In addition, except with respect to its duties under Sections 1(i), (j) or (k) hereof, the Trustee shall be entitled to rely on, and shall be protected in relying on, any verbal or telephonic advice or
    instruction which it, in good faith and with reasonable care, believes to be given by any one of the persons authorized above to give written instructions, provided that the Company shall promptly confirm such instructions in writing;

  

  

  
    3

    
      

  

  (b)     Subject to Section 4 hereof, hold the Trustee harmless and indemnify the Trustee from and against any and all expenses, including reasonable counsel fees
    and disbursements, or losses suffered by the Trustee in connection with any action taken by it hereunder and in connection with any action, suit or other proceeding brought against the Trustee involving any claim, or in connection with any claim or
    demand, which in any way arises out of or relates to this Agreement, the services of the Trustee hereunder, or the Property or any interest earned on the Property, except for expenses and losses resulting from the Trustee’s gross negligence, fraud or
    willful misconduct. Promptly after the receipt by the Trustee of notice of demand or claim or the commencement of any action, suit or proceeding, pursuant to which the Trustee intends to seek indemnification under this Section 2(b), it shall
    notify the Company in writing of such claim (hereinafter referred to as the “Indemnified Claim”). The Trustee shall have the right to conduct and manage the defense against such Indemnified
    Claim; provided that the Trustee shall obtain the consent of the Company with respect to the selection of counsel, which consent shall not be unreasonably withheld. The Trustee may not agree to settle any Indemnified Claim without the prior
    written consent of the Company, which such consent shall not be unreasonably withheld. The Company may participate in such action with its own counsel;

  

  

  (c)      Pay the Trustee the fees set forth on Schedule A hereto, including an initial acceptance fee, annual administration fee, and transaction processing fee
    which fees shall be subject to modification by the parties from time to time. It is expressly understood that the Property shall not be used to pay such fees unless and until it is distributed to the Company pursuant to Sections 1(i) through 1(k)
    hereof. The Company shall pay the Trustee the initial acceptance fee and the first annual administration fee at the consummation of the Offering. The Company shall not be responsible for any other fees or charges of the Trustee except as set forth in
    this Section 2(c) and as may be provided in Section 2(b) hereof;

   

  

  (d)     In connection with any vote of the Company’s stockholders regarding a merger, share exchange, asset acquisition, share purchase, reorganization or similar
    business combination involving the Company and one or more businesses (the “Business Combination”), provide to the Trustee an affidavit or certificate of the inspector of elections for the
    stockholder meeting verifying the vote of such stockholders regarding such Business Combination;

  

  

  (e)      Provide the Representatives with a copy of any Termination Letter(s) and/or any other correspondence that is sent to the Trustee with respect to any proposed
    withdrawal from the Trust Account promptly after it issues the same;

  

  

  (f)       Unless otherwise agreed in writing between the Company and the Representatives, ensure that any Instruction Letter (as defined in Exhibit A) delivered
    in connection with a Termination Letter in the form of Exhibit A expressly provides that the Deferred Discount is paid directly to the account or accounts directed by the Representatives on behalf of the Underwriters prior to any transfer of
    the funds held in the Trust Account to the Company or any other person;

  

  

  (g)       Instruct the Trustee to make only those distributions that are permitted under this Agreement, and refrain from instructing the Trustee to make any
    distributions that are not permitted under this Agreement;

  

  

  
    4

    
      

  

  (h)       If the Company seeks to amend any provisions of its certificate of incorporation (as amended) (A) to modify the substance or timing of the Company’s obligation
    to provide holders of the Common Stock the right to have their shares redeemed in connection with the Company’s initial Business Combination or to redeem 100% of the Common Stock if the Company does not complete its initial Business Combination within
    the time period set forth therein or (B) with respect to any other provision relating to the rights of holders of the Common Stock (in each case, an “Amendment”), the Company will provide the
    Trustee with a letter in the form of Exhibit D providing instructions for the distribution of funds to Public Stockholders who exercise their redemption option in connection with such Amendment; and

  

  

  (i)        Within five (5) business days after the Underwriters exercise their option to purchase additional units (or any unexercised portion thereof) or such option to
    purchase additional units expires, provide the Trustee with a notice in writing of the total amount of the Deferred Discount.

  

  

  3.            Limitations of Liability. The Trustee shall have no responsibility or liability to:

  

  

  (a)     Imply obligations, perform duties, inquire or otherwise be subject to the provisions of any agreement or document other than this Agreement and that which is
    expressly set forth herein;

  

  

  (b)       Take any action with respect to the Property, other than as directed in Section 1 hereof, and the Trustee shall have no liability to any third party
    except for liability arising out of the Trustee’s gross negligence, fraud or willful misconduct;

  

  

  (c)       Institute any proceeding for the collection of any principal and income arising from, or institute, appear in or defend any proceeding of any kind with respect
    to, any of the Property unless and until it shall have received written instructions from the Company given as provided herein to do so and the Company shall have advanced or guaranteed to it funds sufficient to pay any expenses incident thereto;

  

  

  (d)        Change the investment of any Property, other than in compliance with Section 1 hereof;

  

  

  (e)        Refund any depreciation in principal of any Property;

  

  

  (f)       Assume that the authority of any person designated by the Company to give instructions hereunder shall not be continuing unless provided otherwise in such
    designation, or unless the Company shall have delivered a written revocation of such authority to the Trustee;

  

  

  (g)       The other parties hereto or to anyone else for any action taken or omitted by it, or any action suffered by it to be taken or omitted, in good faith and in the
    Trustee’s best judgment, except for the Trustee’s gross negligence, fraud or willful misconduct. The Trustee may rely conclusively and shall be protected in acting upon any order, notice, demand, certificate, opinion or advice of counsel (including
    counsel chosen by the Trustee, which counsel may be the Company’s counsel), statement, instrument, report or other paper or document (not only as to its due execution and the validity and effectiveness of its provisions, but also as to the truth and
    acceptability of any information therein contained) which the Trustee believes, in good faith and with reasonable care, to be genuine and to be signed or presented by the proper person or persons. The Trustee shall not be bound by any notice or demand,
    or any waiver, modification, termination or rescission of this Agreement or any of the terms hereof, unless evidenced by a written instrument delivered to the Trustee, signed by the proper party or parties and, if the duties or rights of the Trustee
    are affected, unless it shall give its prior written consent thereto;

  

  

  
    5

    
      

  

  (h)        Verify the accuracy of the information contained in the Registration Statement;

  

  

  (i)       Provide any assurance that any Business Combination entered into by the Company or any other action taken by the Company is as contemplated by the Registration
    Statement;

  

  

  (j)       File information returns with respect to the Trust Account with any local, state or federal taxing authority or provide periodic written statements to the
    Company documenting the taxes payable by the Company, if any, relating to any interest income earned on the Property;

  

  

  (k)       Prepare, execute and file tax reports, income or other tax returns and pay any taxes with respect to any income generated by, and activities relating to, the
    Trust Account, regardless of whether such tax is payable by the Trust Account or the Company, including, but not limited to, income tax obligations, except pursuant to Section 1(j) hereof; or

  

  

  (l)        Verify calculations, qualify or otherwise approve the Company’s written requests for distributions pursuant to Sections 1(i), 1(j) or 1(k)
    hereof.

  

  

  4.           Trust Account Waiver. The Trustee has no right of set-off or any right, title, interest or claim of any kind (“Claim”) to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it may have now or in the future. In the event the Trustee has any Claim against
    the Company under this Agreement, including, without limitation, under Section 2(b) or Section 2(c) hereof, the Trustee shall pursue such Claim solely against the Company and its assets outside the Trust Account and not against the
    Property or any monies in the Trust Account.

  

  

  5.            Termination. This Agreement shall terminate as follows:

  

  

  (a)       If the Trustee gives written notice to the Company that it desires to resign under this Agreement, the Company shall use its reasonable efforts to locate a
    successor trustee, pending which the Trustee shall continue to act in accordance with this Agreement. At such time that the Company notifies the Trustee that a successor trustee has been appointed by the Company and has agreed to become subject to the
    terms of this Agreement, the Trustee shall transfer the management of the Trust Account to the successor trustee, including but not limited to the transfer of copies of the reports and statements relating to the Trust Account, whereupon this Agreement
    shall terminate; provided, however, that in the event that the Company does not locate a successor trustee within ninety (90) days of receipt of the resignation notice from the Trustee, the Trustee may submit an application to have the
    Property deposited with any court in the State of New York or with the United States District Court for the Southern District of New York and upon such deposit, the Trustee shall be immune from any liability whatsoever; or

  

  

  (b)       At such time that the Trustee has completed the liquidation of the Trust Account and its obligations in accordance with the provisions of Section 1(i)
    hereof and distributed the Property in accordance with the provisions of the Termination Letter, this Agreement shall terminate except with respect to Section 2(b).

  

  

  
    6

    
      

  

  6.            Miscellaneous.

  

  

  (a)       The Company and the Trustee each acknowledge that the Trustee will follow the security procedures set forth below with respect to funds transferred from the
    Trust Account. The Company and the Trustee will each restrict access to confidential information relating to such security procedures to authorized persons. Each party must notify the other party immediately if it has reason to believe unauthorized
    persons may have obtained access to such confidential information, or of any change in its authorized personnel. In executing funds transfers, the Trustee shall rely upon all information supplied to it by the Company, including, account names, account
    numbers, and all other identifying information relating to a Beneficiary, Beneficiary’s bank or intermediary bank. Except for any liability arising out of the Trustee’s gross negligence, fraud or willful misconduct, the Trustee shall not be liable for
    any loss, liability or expense resulting from any error in the information or transmission of the funds.

  

  

  (b)       This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect to conflicts of law
    principles that would result in the application of the substantive laws of another jurisdiction. This Agreement may be executed in several original or facsimile counterparts, each one of which shall constitute an original, and together shall constitute
    but one instrument.

  

  

  (c)       This Agreement contains the entire agreement and understanding of the parties hereto with respect to the subject matter hereof. Except for Section 1(i),
    1(j) and 1(k) hereof (which sections may not be modified, amended or deleted without the affirmative vote of sixty-five percent (65%) of the then outstanding Common Stock and Class B common stock, par value $0.0001 per share, of the
    Company, voting together as a single class; provided that no such amendment will affect any Public Stockholder who has properly elected to redeem his or her Common Stock in connection with a stockholder vote to amend this Agreement to modify
    the substance or timing of the Company’s obligation to provide for the redemption of the Common Stock in connection with an initial Business Combination or an Amendment or to redeem 100% of its Common Stock if the Company does not complete its initial
    Business Combination within the time frame specified in the Company’s certificate of incorporation (as amended)), this Agreement or any provision hereof may only be changed, amended or modified (other than to correct a typographical error) by a writing
    signed by each of the parties hereto.

  

  

  (d)        The parties hereto consent to the jurisdiction and venue of any state or federal court located in the City of New York, State of New York, for purposes of
    resolving any disputes hereunder. AS TO ANY CLAIM, CROSS-CLAIM OR COUNTERCLAIM IN ANY WAY RELATING TO THIS AGREEMENT, EACH PARTY WAIVES THE RIGHT TO TRIAL BY JURY.

  

  

  
    7

    
      

  

  (e)       Any notice, consent or request to be given in connection with any of the terms or provisions of this Agreement shall be in writing and shall be sent by express
    mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or by electronic mail:

  

  

  
    	 	
            if to the Trustee, to:

          
	 	 	 
	 	 	
            [Continental Stock Transfer & Trust Company

          
	 	 	
            1 State Street, 30th Floor

          
	 	 	
            New York, New York 10004

          
	 	 	
            Attn: 

          	
            Francis E. Wolf, Jr. & Celeste Gonzalez

          
	 	 	
            Email: 

          	
            fwolf@continentalstock.com

          
	 	 	 	
            cgonzalez@continentalstock.com]

          
	 	 	 
	 	
            if to the Company, to:

          
	 	 	 
	 	 	
            Focus Impact Acquisition Corp.

          
	 	 	
            250 Park Avenue Ste 911

          
	 	 	
            New York, NY, 10177

          
	 	 	
            Attn: 

          	
            Chief Executive Officer

            

          
	 	 	
            Email: 

          	
            carl@cbgrowthgroup.com

            

          
	 	 	 
	 	
            in each case, with copies to:

          
	 	 	 
	 	 	
            Kirkland & Ellis LLP

          
	 	 	
            601 Lexington Avenue

          
	 	 	
            New York, New York 10022

          
	 	 	
            Attn: 

          	
            Christian O. Nagler

          
	 	 	 	
            Peter S. Seligson

          
	 	 	
            Email: 

          	
            cnagler@kirkland.com

          
	 	 	 	
            peter.seligson@kirkland.com

          
	 	 	 
	 	
            and

          
	 	 	 
	 	 	
            Citigroup Global Markets Inc.

          
	 	 	
            388 Greenwich Street

          
	 	 	
            New York, New York 10013

          
	 	 	
            Attn: 

          	
            [Bridget Fawcett]

          
	 	 	
            Email: 

          	
            [bridget.fawcett@citi.com]

            

          
	 	 	 
	 	
            and

          
	 	 	 
	 	 	
            Sidley Austin LLP

          
	 	 	
            787 Seventh Avenue

          
	 	 	
            New York, New York 10019

          
	 	 	
            Attn.: 

          	
            Michael P. Heinz

          
	 	 	 	
            William J. Cooper

          
	 	 	
            Email: 

          	
            mheinz@sidley.com

          
	 	 	 	
            wcooper@sidley.com

          

  

  

  

  (f)        Each of the Company and the Trustee hereby represents that it has the full right and power and has been duly authorized to enter into this Agreement and to
    perform its respective obligations as contemplated hereunder. The Trustee acknowledges and agrees that it shall not make any claims or proceed against the Trust Account, including by way of set-off, and shall not be entitled to any funds in the Trust
    Account under any circumstance.

  

  

  
    8

    
      

  

  (g)      This Agreement is the joint product of the Trustee and the Company and each provision hereof has been subject to the mutual consultation, negotiation and
    agreement of such parties and shall not be construed for or against any party hereto.

  

  

  (h)      This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together
    constitute one and the same instrument. Delivery of a signed counterpart of this Agreement by facsimile or electronic transmission shall constitute valid and sufficient delivery thereof. The words “execution,” “signed,” “signature,” and words of like
    import in this Agreement or in any other certificate, agreement or document related to this Agreement shall include images of manually executed signatures transmitted by facsimile or other electronic format (including, without limitation, “pdf,” “tif”
    or “jpg”) and other electronic signatures (including, without limitation, DocuSign and AdobeSign). The use of electronic signatures and electronic records (including, without limitation, any contract or other record created, generated, sent,
    communicated, received, or stored by electronic means) shall be of the same legal effect, validity and enforceability as a manually executed signature or use of a paper-based record-keeping system to the fullest extent permitted by applicable law,
    including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act and any other applicable law, including, without limitation, any state law based on the Uniform Electronic
    Transactions Act or the Uniform Commercial Code.

  

  

  

  (i)       Each of the Company and the Trustee hereby acknowledges and agrees that the Representatives on behalf of the Underwriters are third-party beneficiaries of this
    Agreement.

  

  

  (j)        Except as specified herein, no party to this Agreement may assign its rights or delegate its obligations hereunder to any other person or entity.

  

  

  [Signature Page Follows]

  

  

  
    9

    
      

  

  IN WITNESS WHEREOF, the parties have duly executed this Investment Management Trust
      Agreement as of the date first written above.

   

    

  	
           

        	
          CONTINENTAL STOCK TRANSFER & TRUST COMPANY,

        
	
           

        	
          as Trustee

        
	
           

        	
           

        
	
           

        	
          By:

        	
           

        
	
           

        	
           

        	
          Name:

        	
          Francis Wolf

        
	
           

        	
           

        	
          Title:

        	
          Vice President

        
	
           

        	
           

        	
           

        	
           

        
	
           

        	
          FOCUS IMPACT ACQUISITION CORP.

        
	
           

        	
           

        
	
           

        	
          By:

        	
           

        
	
           

        	
           

        	
          Name:

        	
          Ernest Lyles

        
	
           

        	
           

        	
          Title:

        	
          Chief Financial Officer

        

  

  

  
    [Signature page to Investment Management Trust Agreement]

  

  

  

  
    
      

  

  SCHEDULE A

   

  

  	
          Fee Item

        	 	
          Time and method of payment

        	 	
          Amount

        	 
	
          Initial acceptance fee

        	 	
          Initial closing of IPO by wire transfer

        	 	
          $ 

        	
          [3,500.00

        	 
	
          Annual fee

        	 	
          First year, initial closing of IPO by wire transfer; thereafter on the anniversary of the effective date of the IPO by wire transfer or check

        	 	
          $

        	
          10,000.00

        	 
	
          Transaction processing fee for disbursements to Company under Sections 1(i),(j), and (k)

        	 	
          Billed by Trustee to Company under Section 1

        	 	
          $

        	
          250.00

        	
          ]

        
	
          Paying Agent services as required pursuant to Section 1(i) and 1(k)

        	 	
          Billed to Company upon delivery of service pursuant to Section 1(i) and 1(k)

        	 	
          Prevailing rates]

        	 

  

  

  
    
      

  

  EXHIBIT A

  

  

  [Letterhead of Company]

  

  

  [Insert date]

  

  

  Continental Stock Transfer & Trust Company

  1 State Street, 30th Floor

  New York, New York 10004

  Attn: Francis Wolf & Celeste Gonzalez

   

  

  
    
      	 	
              Re:

            	
              Trust Account Termination Letter

            

    

  

   

   

  

  Dear Mr. Wolf and Ms. Gonzalez:

  

  

  Pursuant to Section 1(i) of the Investment Management Trust Agreement between Focus Impact Acquisition Corp. (the “Company”) and Continental Stock Transfer & Trust Company (“Trustee”), dated as of [●], 2021 (the “Trust Agreement”),

    this is to advise you that the Company has entered into an agreement with ___________ (the “Target Business”) to consummate a business combination with Target Business (the “Business Combination”) on or about [insert date]. The Company shall notify you at least seventy-two (72) hours in advance of the actual date (or such
    shorter time period as you may agree) of the consummation of the Business Combination (the “Consummation Date”). Capitalized terms used but not defined herein shall have the meanings set forth
    in the Trust Agreement.

  

  

  In accordance with the terms of the Trust Agreement, we hereby authorize you to commence to liquidate all of the assets of the Trust Account, and to transfer the
    proceeds into the trust operating account at J.P. Morgan Chase Bank, N.A. to the effect that, on the Consummation Date, all of the funds held in the Trust Account will be immediately available for transfer to the account or accounts that the
    Representatives (with respect to the Deferred Discount) and the Company shall direct on the Consummation Date. It is acknowledged and agreed that while the funds are on deposit in said trust operating account at J.P. Morgan Chase Bank, N.A. awaiting
    distribution, neither the Company nor the Representatives will earn any interest or dividends.

  

  

  On the Consummation Date (i) counsel for the Company shall deliver to you written notification that the Business Combination has been consummated, or will be consummated
    substantially concurrently with your transfer of funds to the accounts as directed by the Company (the “Notification”), and (ii) the Company shall deliver to you (a) a certificate by the Chief
    Executive Officer, Chief Financial Officer or other authorized officer of the Company, which verifies that the Business Combination has been approved by a vote of the Company’s stockholders, if a vote is held and (b) joint written instruction signed by
    the Company and the Representatives with respect to the transfer of the funds held in the Trust Account, including payment of the Deferred Discount from the Trust Account (the “Instruction Letter”).

    You are hereby directed and authorized to transfer the funds held in the Trust Account immediately upon your receipt of the Notification and the Instruction Letter, in accordance with the terms of the Instruction Letter. In the event that certain
    deposits held in the Trust Account may not be liquidated by the Consummation Date without penalty, you will notify the Company in writing of the same and the Company shall direct you as to whether such funds should remain in the Trust Account and be
    distributed after the Consummation Date to the Company. Upon the distribution of all the funds, net of any payments necessary for reasonable unreimbursed expenses related to liquidating the Trust Account, your obligations under the Trust Agreement
    shall be terminated.

  

  

  
    
      

  

  In the event that the Business Combination is not consummated on the Consummation Date described in the notice thereof and we have not notified you on or before the
    original Consummation Date of a new Consummation Date, then upon receipt by the Trustee of written instructions from the Company, the funds held in the Trust Account shall be reinvested as provided in Section 1(c) of the Trust Agreement on the business
    day immediately following the Consummation Date as set forth in such notice as soon thereafter as possible.

   

  

  	
           

        	
          Very truly yours,

        
	 	 
	
           

        	
          Focus Impact Acquisition Corp.

        
	
           

        	
           

        
	
           

        	
          By:

        	
           

        
	
           

        	
          Name:

        	
           

        
	
           

        	
          Title:

        	
           

        

  

  

  
    
      

  

  EXHIBIT B

  

  

  [Letterhead of Company]

  

  

  [Insert date]

  

  

  Continental Stock Transfer & Trust Company

  1 State Street, 30th Floor

  New York, New York 10004

  Attn: Francis Wolf & Celeste Gonzalez

   

  

  
    
      
        	 	
                Re:

              	
                Trust Account Termination Letter

              

      

    

  

   

  

  Dear Mr. Wolf and Ms. Gonzalez:

  

  

  Pursuant to Section 1(i) of the Investment Management Trust Agreement between Focus Impact Acquisition Corp. (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of [●], 2021 (the “Trust Agreement”),

    this is to advise you that the Company has been unable to effect a business combination with a Target Business (the “Business Combination”) within the time frame specified in the Company’s
    Certificate of Incorporation (as amended), as described in the Company’s Prospectus relating to the Offering. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.

  

  

  In accordance with the terms of the Trust Agreement, we hereby authorize you to liquidate all of the assets in the Trust Account __________and to transfer the total
    proceeds into the trust operating account at J.P. Morgan Chase Bank, N.A. to await distribution to the Public Stockholders. The Company has selected __________ as the effective date for the purpose of determining when the Public Stockholders will be
    entitled to receive their share of the liquidation proceeds. It is acknowledged that no interest will be earned by the Company on the liquidation proceeds while on deposit in the trust operating account. You agree to be the Paying Agent of record and,
    in your separate capacity as Paying Agent, agree to distribute said funds directly to the Company’s Public Stockholders in accordance with the terms of the Trust Agreement and the Amended and Restated Certificate of Incorporation of the Company. Upon
    the distribution of all the funds, net of any payments necessary for reasonable unreimbursed expenses related to liquidating the Trust Account, your obligations under the Trust Agreement shall be terminated, except to the extent otherwise provided in Section

      1(j) of the Trust Agreement.

   

  

  	
           

        	
          Very truly yours,

        
	 	 
	
           

        	
          Focus Impact Acquisition Corp.

        
	
           

        	
           

        
	
           

        	
          By:

        	
           

        
	
           

        	
          Name:

        	
           

        
	
           

        	
          Title:

        	
           

        
	 	 	 
	
          cc:

        	
          Citigroup Global Markets Inc.

        	
           

        	
           

        

  

  

  
    
      

  

   EXHIBIT C

  

  

  [Letterhead of Company]

  

  

  [Insert date]

  

  

  Continental Stock Transfer & Trust Company

  1 State Street, 30th Floor

  New York, New York 10004

  Attn: Francis Wolf & Celeste Gonzalez

    

    

    
      
        	 	
                Re:

              	
                Trust Account – Tax Payment Withdrawal Instruction

              

      

    

    

  

  Dear Mr. Wolf and Ms. Gonzalez:

  

  

  Pursuant to Section 1(j) of the Investment Management Trust Agreement between Focus Impact Acquisition Corp. (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of [●], 2021 (the “Trust Agreement”),

    the Company hereby requests that you deliver to the Company $___________ of the interest income earned on the Property as of the date hereof. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.

  

  

  The Company needs such funds to pay for the tax obligations as set forth on the attached tax return or tax statement. In accordance with the terms of the Trust
    Agreement, you are hereby directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt of this letter to the Company’s operating account at:

  

  

  [WIRE INSTRUCTION INFORMATION]

   

  

  	
           

        	
          Very truly yours,

        
	 	 
	
           

        	
          Focus Impact Acquisition Corp.

        
	
           

        	
           

        
	
           

        	
          By:

        	
           

        
	
           

        	
          Name:

        	
           

        
	
           

        	
          Title:

        	
           

        
	
          cc:

        	
          Citigroup Global Markets Inc.

        	
           

        	
           

        

  

  

  
    
      

  

  EXHIBIT D

  

  

  [Letterhead of Company]

  

  

  [Insert date]

  

  

  Continental Stock Transfer & Trust Company

  1 State Street, 30th Floor

  New York, New York 10004

  Attn: Francis Wolf & Celeste Gonzalez

   

  

  
    	 	
            Re:

          	
            Trust Account Stockholder Redemption Withdrawal Instruction

          

  

   

  

  Dear Mr. Wolf and Ms. Gonzalez:

  

  

  Pursuant to Section 1(k) of the Investment Management Trust Agreement between Focus Impact Acquisition Corp. (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of [●], 2021 (the “Trust Agreement”),

    the Company hereby requests that you deliver to the Company’s stockholders $___________ of the principal and interest income earned on the Property as of the date hereof. Capitalized terms used but not defined herein shall have the meanings set forth
    in the Trust Agreement.

  

  

  Pursuant to Section 1(k) of the Trust Agreement, this is to advise you that the Company has sought an Amendment. Accordingly, in accordance with the terms of the Trust
    Agreement, we hereby authorize you to liquidate a sufficient portion of the Trust Account and to transfer $[●] of the proceeds of the Trust Account to the trust operating account at J.P. Morgan Chase Bank, N.A. for distribution to the stockholders that
    have requested redemption of their shares in connection with such Amendment.

   

  

  	
           

        	
          Very truly yours,

        
	 	 
	
           

        	
          Focus Impact Acquisition Corp.

        
	 	 
	
           

        	
          By:

        	
           

        
	
           

        	
          Name:

        	
           

        
	
           

        	
          Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]